Viewing Study NCT00313456


Ignite Creation Date: 2025-12-24 @ 11:37 PM
Ignite Modification Date: 2026-01-24 @ 10:32 PM
Study NCT ID: NCT00313456
Status: TERMINATED
Last Update Posted: 2012-05-10
First Post: 2006-04-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Study of the Oral Platinum Agent Satraplatin in Combination With Weekly Docetaxel
Sponsor: Agennix
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Tumors View
None Prostate Cancer View
Keywords: